IITRI

United States Founded: 1936 • Age: 90 yrs Acquired By Alion Science
Bioanalytical services are provided for research and development applications.

About IITRI

IITRI is a company based in United States founded in 1936 was acquired by Alion Science in December 2002. IITRI offers products and services including Toxicology Services, Biodefense Services, Inhalation Toxicology, and Immunology Services. IITRI operates in a competitive market with competitors including Advion, BioAgilytix, Tentamus, Alderley Analytical and Evans Analytical Group, among others.

  • Headquarter United States
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website iitri.org
  • Social LinkedIn X Facebook
  • Acquired by Alion Science (Dec 2002)
  • Legal Name Iit Research Institute
Key Metrics
  • Latest Funding Round
    $1.82M (USD), Grant

    Dec 2010

  • Investors
    HHS

    & 1 more

  • Acquired by
    Alion Science

    (Dec 2002)

Products & Services of IITRI

IITRI offers a comprehensive portfolio of products and services, including Toxicology Services, Biodefense Services, Inhalation Toxicology, and Immunology Services.

Toxicology Services
Safety Testing

Preclinical toxicology evaluation for drug safety and regulatory compliance.

Biodefense Services
Infectious Disease Studies

Development of vaccines and therapeutics against pathogens.

Inhalation Toxicology
Pulmonary Testing

Studies on inhaled drugs and aerosol challenges for safety.

Immunology Services
Bioanalytical Support

Assays for immunogenicity and cellular responses in trials.

Funding Insights of IITRI

  • Total Rounds 4
  • Last Round Grant β€” $1.82M
  • First Round $1.12M

    (Jul 2007)

  • Investors Count 1

All 4 funding rounds of IITRI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2010$1.82MGrant––
May 2010$1.12MGrant––
Aug 2008$266,752Grant––
Jul 2007$1.12MGrant––
Valuation history

2 investors in total: 2 institutional.

Investors in IITRI

IITRI has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Alion Science.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Technology solutions are provided to U.S. federal government agencies.
1936alionscience.comMclean, United States
Premium access

Investor details for IITRI

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of IITRI

12 people are tracked at IITRI (5 in leadership, 7 in team).

NameRoleGroup
Glenn Miller
Assistant Vice President And ManagerLeadership
Todd Bucciarelli
Assistant VP & Director of Business DevelopmentLeadership
David L. McCormick
PresidentLeadership
William D. Johnson
Assistant VP & Manager of Toxicology DivisionLeadership
Fannell Matthews
Assistant Vice President Of Administration And Manager Of FinanceLeadership
Israr Ahmad
Senior ToxicologistTeam
Larry N.
Project Financial AnalystTeam
Mary Smeaton
HR ManagerTeam
Patti Paas
Senior Human Resources AssociateTeam
Landon Westfall
Division Manager Microbiology And Molecular BiologyTeam
Justin Mussman
Laboratory Biologist IITeam
Sridhar Jaligama
Manager of Inhalation ToxicologyTeam
Premium access

Complete people profiles for IITRI

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of IITRI

4 dated milestones of IITRI across 74 years, from founding to its latest funding, stage changes and deals.

  1. Founded IITRI is founded.
  2. Exit Acquired by Alion Science.
  3. Funding First funding round of $1.1M.
  4. Funding Latest funding round, Grant, of $1.8M.

Competitors of IITRI

IITRI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advion, BioAgilytix, Tentamus, Alderley Analytical and Evans Analytical Group, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
advion.com1993Ithaca, United States$45.64M54
Microfluidics and mass spectrometry products are provided for clinical research.
bioagilytix.com2008Durham, United States–446
Large-molecule bioanalysis is provided for biologics and biosimilars development.
tentamus.com2011Berlin, Germany–368
Analytical and quality assurance services are provided for diverse industries.
alderleyanalytical.com2013Stockport, United Kingdom$869,35241
Bioanalytical assays for drug development are developed and validated.
eag.com1978San Diego, United States–601
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
apocell.com2004Houston, United States–2,198
Provider of clinical trial and clinical development on bioanalytical services
nordicbioscience.com1996Herlev, Denmark–178
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
nuvisan.com1979Neu Ulm, Germany–1,011
Clinical trial supply and bioanalytical services are provided globally.
lightcast.bio2019Cambridge, United Kingdom$107.09M25
Advanced single-cell analysis solutions are provided for biotechnology research.
immunxperts.com2014Charleroi, Belgium$1M22
Human immune system-based bioassays are developed for drug applications.
Premium access

Detailed competitors of IITRI

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of IITRI

The website of IITRI (iitri.org) receives about 2.4K visits a month.

  • Monthly visits
    2.4K

    ▼ 38% vs previous month

Similar companies to IITRI

10 companies that operate in the same segment as IITRI (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about IITRI

IITRI was founded in 1936 and raised its 1st funding round 71 years after it was founded.

IITRI is headquartered in United States.

The company was founded in 1936 in the United States as a provider of bioanalytical services. Operations are centered in the biotechnology sector, where analytical testing and data support are delivered to clients in pharmaceuticals and life sciences. Services encompass bioanalytical methods for drug discovery and validation, conducted through established laboratory facilities. The domain iitri.org serves as the primary online platform for information and outreach.

IITRI's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.

IITRI offers Toxicology Services, Biodefense Services, Inhalation Toxicology, and Immunology Services.

IITRI has 2 investors. Key investors include HHS, and Alion Science.

IITRI operates through Iit Research Institute.

Yes. IITRI was acquired by Alion Science in December 2002.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available